---
title: "Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288476041.md"
description: "Gilead Sciences (GILD) shares fell 2.69% to $127.57 on Tuesday, underperforming the broader market and key competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories. This marks the third consecutive day of losses for Gilead, which remains 18.90% below its 52-week high. Trading volume reached 8.0 million, exceeding the 50-day average."
datetime: "2026-06-02T20:35:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288476041.md)
  - [en](https://longbridge.com/en/news/288476041.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288476041.md)
---

# Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Gilead Sciences Inc. (GILD) shed 2.69% to $127.57 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.13% to 7,609.78 and the Dow Jones Industrial Average rising 0.45% to 51,307.79.

This was the stock's third consecutive day of losses.

Gilead Sciences Inc. closed 18.90% short of its 52-week high of $157.29, which the company reached on February 11th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.28% to $222.89, Pfizer Inc. (PFE) fell 0.31% to $25.55, and Abbott Laboratories (ABT) fell 0.92% to $86.97.

Trading volume (8.0 M) eclipsed its 50-day average volume of 6.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-02-26 1635ET

### Related Stocks

- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [Gilead Sciences, Inc. $GILD Shares Sold by BI Asset Management Fondsmaeglerselskab A S](https://longbridge.com/en/news/288924413.md)
- [Gilead And Lakefront Acquire Ouro Medicines In $1.67 Bln Agreement; To Co-Develop Gamgertamig](https://longbridge.com/en/news/288851463.md)
- [Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa | GILD Stock News](https://longbridge.com/en/news/288820076.md)
- [Gilead Advances Liver Disease Ambitions With Encouraging Study Outcome](https://longbridge.com/en/news/288463750.md)
- [Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline | GILD Stock News](https://longbridge.com/en/news/288769642.md)